Study of a Neurocognition Enhancing Agent in Patients With Schizophrenia
Condition(s):SchizophreniaLast Updated:October 6, 2011Completed
Hide Studies Not Open or Pending
Condition(s):SchizophreniaLast Updated:October 6, 2011Completed
Condition(s):Cognitive ImpairmentLast Updated:December 1, 2022Completed
Condition(s):Metabolic SyndromeLast Updated:March 9, 2022Completed
Condition(s):StrokeLast Updated:September 13, 2017Completed
Condition(s):Cognitive Fatigue; Mental Fatigue; Behavioral Performance; Heart Rate Variability; Positive and Negative Affect; Inhibition, Psychological; Working Memory; Perceived RestorationLast Updated:March 23, 2023Recruiting
Condition(s):Cognitive Fatigue; Mental Fatigue; Behavioral Performance; Heart Rate Variability; Working MemoryLast Updated:January 11, 2023Recruiting
Condition(s):Cognitive Fatigue; Mental Fatigue; Behavioral Performance; Heart Rate Variability; Skin Conductance; Academic Performance; Self-regulationLast Updated:March 23, 2023Recruiting
Condition(s):Cognitive Fatigue; Mental Fatigue; Behavioral Performance; Heart Rate Variability; Skin ConductanceLast Updated:March 23, 2023Recruiting
Condition(s):Cognitive Fatigue; Mental Fatigue; Heart Rate Variability; Skin Conductance; Behavioral Performance; Positive and Negative Affect; Inhibition; Working Memory; Perceived RestorationLast Updated:March 23, 2023Recruiting
Condition(s):TrichotillomaniaLast Updated:June 13, 2018Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.